Stephens Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Buy
10,846
+1,046
+11% +$112K 0.02% 589
2025
Q1
$989K Sell
9,800
-746
-7% -$75.3K 0.01% 615
2024
Q4
$942K Buy
10,546
+148
+1% +$13.2K 0.01% 628
2024
Q3
$871K Sell
10,398
-15,654
-60% -$1.31M 0.01% 642
2024
Q2
$2.01M Buy
26,052
+16,404
+170% +$1.26M 0.03% 431
2024
Q1
$661K Sell
9,648
-10
-0.1% -$685 0.01% 710
2023
Q4
$558K Sell
9,658
-31,481
-77% -$1.82M 0.01% 705
2023
Q3
$2.17M Buy
41,139
+2,012
+5% +$106K 0.04% 350
2023
Q2
$2.12M Sell
39,127
-27,979
-42% -$1.51M 0.04% 368
2023
Q1
$3.36M Buy
67,106
+18,881
+39% +$945K 0.06% 287
2022
Q4
$2.23M Buy
48,225
+37,711
+359% +$1.74M 0.05% 344
2022
Q3
$407K Sell
10,514
-477
-4% -$18.5K 0.01% 777
2022
Q2
$410K Sell
10,991
-3,555
-24% -$133K 0.01% 799
2022
Q1
$644K Sell
14,546
-4,857
-25% -$215K 0.01% 723
2021
Q4
$824K Buy
19,403
+4,540
+31% +$193K 0.01% 690
2021
Q3
$645K Sell
14,863
-1,570
-10% -$68.1K 0.01% 774
2021
Q2
$703K Sell
16,433
-871
-5% -$37.3K 0.01% 761
2021
Q1
$669K Sell
17,304
-749
-4% -$29K 0.01% 749
2020
Q4
$649K Buy
18,053
+5
+0% +$180 0.01% 710
2020
Q3
$690K Buy
18,048
+132
+0.7% +$5.05K 0.01% 648
2020
Q2
$629K Buy
17,916
+3,777
+27% +$133K 0.01% 644
2020
Q1
$461K Sell
14,139
-96
-0.7% -$3.13K 0.01% 668
2019
Q4
$644K Sell
14,235
-50
-0.4% -$2.26K 0.01% 663
2019
Q3
$581K Buy
14,285
+1,926
+16% +$78.3K 0.01% 709
2019
Q2
$531K Sell
12,359
-1,263
-9% -$54.3K 0.01% 744
2019
Q1
$523K Sell
13,622
-8,429
-38% -$324K 0.01% 749
2018
Q4
$779K Sell
22,051
-25,003
-53% -$883K 0.02% 577
2018
Q3
$1.81M Buy
+47,054
New +$1.81M 0.05% 420
2017
Q2
Sell
-53,795
Closed -$1.34M 875
2017
Q1
$1.34M Buy
+53,795
New +$1.34M 0.05% 360
2016
Q2
Sell
-10,683
Closed -$201K 770
2016
Q1
$201K Sell
10,683
-2,230
-17% -$42K 0.01% 654
2015
Q4
$238K Buy
12,913
+308
+2% +$5.68K 0.01% 604
2015
Q3
$207K Buy
12,605
+995
+9% +$16.3K 0.01% 639
2015
Q2
$205K Buy
+11,610
New +$205K 0.01% 703